Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

<p>Abstract</p> <p>Background</p> <p>A rise in gastrointestinal (GI) adverse events (AEs) and a decline in bone mineral density (BMD) was observed in patients previously tolerant to brand alendronate shortly after generic versions were introduced in July 2005 to the Can...

Full description

Bibliographic Details
Main Authors: Papaioannou Alexandra, Grima Daniel T, Airia Parisa, Ioannidis George, Adachi Jonathan D
Format: Article
Language:English
Published: BMC 2010-04-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/11/68

Similar Items

Similar Items